One major reason these cardiovascular benefits are underappreciated is the predominant focus on sexual health when prescribing Extra Super Vidalista. Doctors and patients alike tend to associate the medication strictly with treating ED and PE, ignoring its systemic effects. Furthermore, there is limited awareness and education about PDE5 inhibitors’ cardiovascular effects among primary care physicians and cardiologists. Treatment guidelines for cardiovascular diseases have yet to integrate tadalafil or similar drugs as adjunct therapy, partly because most clinical trials have focused on sexual dysfunction outcomes rather than long-term cardiovascular endpoints.
https://www.flatmeds.com/produ....ct/extra-super-vidal